Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10420306 | 0.77 | ACHE (0.47) | ACHEBCHE | |
| SCHEMBL7046862 | 0.74 | ACHE (0.44) | ACHEBCHE | |
| SCHEMBL10419371 | 0.70 | ACHE (0.42) | ACHEBCHE | |
| Bromide SCHEMBL6704513 | 0.69 | ACHE (0.41) | ACHEBCHE | |
| Hydrochloric Acid SCHEMBL6704055 | 0.69 | ACHE (0.43) | ACHEBCHE | |
| SCHEMBL901706 | 0.69 | ACHE (0.46) | ACHEBCHE | |
| SCHEMBL9935936 | 0.67 | ACHE (0.68) | ACHEBCHE | |
| SCHEMBL12903650 | 0.67 | BCHE (0.83) | ACHEBCHE | |
| SCHEMBL10005295 | 0.64 | BCHE (1.00) | ACHEBCHE | |
| Hydroxyamine SCHEMBL4937262 | 0.64 | ACHE (0.48) | ACHEBCHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2201070-B1 | AZO QUINOLINIUM COMPOUNDS COMPRISING A DISULPHIDE/THIOL UNIT, COMPOSITIONS CONTAINING SAME, PROCESS FOR DYEING KERATIN FIBRES AND DEVICE | OREAL (FR) | 2011-11-09 | — | — | EP | disclosed |
| US-7967872-B2 | Azo quinolinium compounds comprising a disulphide/thiol unit, compositions containing same, process for dyeing keratin fibres and device | L'OREAL S.A. (FR) | 2011-06-28 | — | — | US | disclosed |
| US-20100263139-A1 | AZO QUINOLINIUM COMPOUNDS COMPRISING A DISULPHIDE/THIOL UNIT, COMPOSITIONS CONTAINING SAME, PROCESS FOR DYEING KERATIN FIBRES AND DEVICE | L'OREAL S.A. (FR) | 2010-10-21 | — | — | US | disclosed |
| EP-2201070-A2 | AZO QUINOLINIUM COMPOUNDS COMPRISING A DISULPHIDE/THIOL UNIT, COMPOSITIONS CONTAINING SAME, PROCESS FOR DYEING KERATIN FIBRES AND DEVICE | L'Oreal (FR) | 2010-06-30 | — | — | EP | disclosed |
| WO-2009034059-A2 | AZO QUINOLINIUM COMPOUNDS COMPRISING A DISULPHIDE/THIOL UNIT, COMPOSITIONS CONTAINING SAME, PROCESS FOR DYEING KERATIN FIBRES AND DEVICE | L'OREAL (FR) | 2009-03-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100263139-A1 | AZO QUINOLINIUM COMPOUNDS COMPRISING A DISULPHIDE/THIOL UNIT, COMPOSITIONS CONTAINING SAME, PROCESS FOR DYEING KERATIN FIBRES AND DEVICE | KRT18, SQOR, DSG1 | ACHE 833/4885BCHE 1952/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.